United Therapeutics Corp (UTHR)
262.40
+4.27
(+1.65%)
USD |
NASDAQ |
May 03, 16:00
262.33
-0.07
(-0.03%)
After-Hours: 20:00
United Therapeutics 1 Year Total Returns (Daily): 20.15% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 20.15% |
| May 02, 2024 | 12.82% |
| May 01, 2024 | 9.92% |
| April 30, 2024 | 1.83% |
| April 29, 2024 | 3.53% |
| April 26, 2024 | 3.53% |
| April 25, 2024 | 4.26% |
| April 24, 2024 | 3.82% |
| April 23, 2024 | 1.61% |
| April 22, 2024 | 1.43% |
| April 19, 2024 | 4.96% |
| April 18, 2024 | 3.93% |
| April 17, 2024 | 2.15% |
| April 16, 2024 | 1.34% |
| April 15, 2024 | 2.78% |
| April 12, 2024 | 3.01% |
| April 11, 2024 | 4.83% |
| April 10, 2024 | 6.60% |
| April 09, 2024 | 4.34% |
| April 08, 2024 | 4.30% |
| April 05, 2024 | 0.24% |
| April 04, 2024 | 2.97% |
| April 03, 2024 | 2.61% |
| April 02, 2024 | 2.06% |
| April 01, 2024 | 1.92% |
| Date | Value |
|---|---|
| March 28, 2024 | 4.93% |
| March 27, 2024 | 11.59% |
| March 26, 2024 | 12.69% |
| March 25, 2024 | 11.06% |
| March 22, 2024 | 11.70% |
| March 21, 2024 | 6.57% |
| March 20, 2024 | 5.16% |
| March 19, 2024 | 8.95% |
| March 18, 2024 | 6.48% |
| March 15, 2024 | 8.40% |
| March 14, 2024 | 7.91% |
| March 13, 2024 | 7.36% |
| March 12, 2024 | 7.91% |
| March 11, 2024 | 9.07% |
| March 08, 2024 | 9.17% |
| March 07, 2024 | 1.35% |
| March 06, 2024 | -4.46% |
| March 05, 2024 | -7.59% |
| March 04, 2024 | -8.02% |
| March 01, 2024 | -5.30% |
| February 29, 2024 | -8.29% |
| February 28, 2024 | -7.62% |
| February 27, 2024 | -8.17% |
| February 26, 2024 | -10.48% |
| February 23, 2024 | -8.59% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-40.52%
Minimum
Jul 23 2019
114.6%
Maximum
Mar 18 2021
19.62%
Average
17.85%
Median
May 19 2023
1 Year Total Returns (Daily) Benchmarks
| Liquidia Corp | 81.42% |
| Esperion Therapeutics Inc | 52.94% |
| Vertex Pharmaceuticals Inc | 15.80% |
| Heron Therapeutics Inc | 12.02% |
| Aldeyra Therapeutics Inc | -59.14% |